文献速递心律失常

植入式心律转复除颤器在既往未诊断的儿茶酚胺敏感性多形性室速心脏骤停复苏患者中的应用

Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.
PubMed 文献 · Eur Heart J · 2019-01-01

本研究分析了136例以心脏骤停(SCA)为首发表现、随后确诊为儿茶酚胺敏感性多形性室速(CPVT)并接受指南导向治疗(β受体阻滞剂、氟卡尼和/或左心交感神经去神经术)的患者,其中79例(58.1%)植入了植入式心律转复除颤器(ICD)。中位随访4.8年后,ICD组与未植入ICD组的SCD发生率无显著差异(3.8% vs 0%,P=0.1),但ICD组SCD、SCA或适当ICD电击的复合终点发生率显著更高(46.8% vs 15.8%,P<0.0001),且不适当ICD电击发生率为24.7%,其他装置相关并发症发生率为28.9%。结论认为,对于此类患者,ICD并未改善生存,反而与高比例的适当和不适当电击及装置相关并发症相关,严格遵循指南导向治疗而不植入ICD可能提供足够保护。

要点

  • ICD未改善既往未诊断CPVT患者SCA后的生存。
  • ICD组适当电击和不适当电击发生率均较高。
  • 严格指南导向药物治疗可能足以提供保护。

核心结论

  • 在既往未诊断的CPVT患者中,以SCA为首发表现后植入ICD并未改善生存,反而与高比例的适当和不适当ICD电击及装置相关并发症相关。

研究设计与样本

  • 回顾性分析136例以SCA为首发表现、随后确诊CPVT并接受指南导向治疗的患者,其中79例(58.1%)植入ICD。

主要发现

  • 中位随访4.8年,ICD组SCD发生3例(3.8%),无ICD组0例(P=0.1)。
  • ICD组SCD、SCA或适当ICD电击复合终点发生37例(46.8%),无ICD组9例(15.8%)(P<0.0001)。
  • 不适当ICD电击发生19例(24.7%),其他装置相关并发症发生22例(28.9%)。

临床怎么用

  • 对于既往未诊断的CPVT患者,SCA后应严格遵循指南导向治疗(β受体阻滞剂、氟卡尼和/或左心交感神经去神经术),植入ICD需权衡电击及并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: In patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), implantable cardioverter-defibrillator (ICD) shocks are sometimes ineffective and may even trigger fatal electrical storms. We assessed the efficacy and complications of ICDs placed in patients with CPVT who presented with a sentinel event of sudden cardiac arrest (SCA) while undiagnosed and therefore untreated. METHODS AND RESULTS: We analysed 136 patients who presented with SCA and in whom CPVT was diagnosed subsequently, leading to the initiation of guideline-directed therapy, including β-blockers, flecainide, and/or left cardiac sympathetic denervation. An ICD was implanted in 79 patients (58.1%). The primary outcome of the study was sudden cardiac death (SCD). The secondary outcomes were composite outcomes of SCD, SCA, appropriate ICD shocks, and syncope. After a median follow-up of 4.8 years, SCD had occurred in three patients (3.8%) with an ICD and none of the patients without an ICD (P = 0.1). SCD, SCA, or appropriate ICD shocks occurred in 37 patients (46.8%) with an ICD and 9 patients (15.8%) without an ICD (P < 0.0001). Inappropriate ICD shocks occurred in 19 patients (24.7%) and other device-related complications in 22 patients (28.9%). CONCLUSION: In previously undiagnosed patients with CPVT who presented with SCA, an ICD was not associated with improved survival. Instead, the ICD was associated with both a high rate of appropriate ICD shocks and inappropriate ICD shocks along with other device-related complications. Strict adherence to guideline-directed therapy without an ICD may provide adequate protection in these patients without all the potential disadvantages of an ICD.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. van der Werf C, Lieve KV, Bos JM, et al. Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest. Eur Heart J. 2019. PMID: 31145795. doi:10.1093/eurheartj/ehz309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。